tiprankstipranks
Trending News
More News >
BioStem Technologies Inc (BSEM)
OTHER OTC:BSEM
US Market

BioStem Technologies (BSEM) Income Statement

Compare
214 Followers

BioStem Technologies Income Statement

Last quarter (Q4 2024), BioStem Technologies's total revenue was $102.87M, an increase of 799.11% from the same quarter last year. In Q4, BioStem Technologies's net income was $15.52M. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 301.83M$ 16.69M$ 6.88M$ 4.34M$ 2.52M
Gross Profit
$ 287.86M$ 15.42M$ 5.99M$ 2.87M$ 1.25M
Operating Expenses
$ 256.66M$ 23.20M$ 10.67M$ 4.47M$ 3.09M
Depreciation and Amortization
$ 293.22K$ 229.02K$ 243.42K$ 283.90K$ 268.58K
EBITDA
$ 31.49M$ -7.55M$ -6.52M$ -602.00K$ -1.59M
Operating Income
$ 31.20M$ -7.78M$ -4.68M$ -1.61M$ -1.84M
Other Income/Expenses
$ -587.22K$ -704.01K$ -2.43M$ 193.93K$ -526.97K
Pretax Income
$ 30.61M$ -8.48M$ -7.11M$ -1.41M$ -2.37M
Net Income
$ 31.88M$ -8.48M$ -7.07M$ -1.45M$ -2.39M
Per Share Metrics
Basic EPS
$ 1.95$ -0.62$ -0.62$ -0.12$ -0.26
Diluted EPS
$ 1.47$ -0.62$ -0.62$ -0.12$ -0.26
Weighted Average Shares Outstanding
16.37M 13.71M 11.41M 11.69M 9.18M
Weighted Average Shares Outstanding (Diluted)
21.70M 13.71M 11.41M 11.69M 9.18M
Currency in USD

BioStem Technologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis